Volume 4.42 | Oct 24

Extracellular Matrix News 4.42 October 24, 2013
Extracellular Matrix News
     In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
Cell Therapy News on Facebook  Extracellular Matrix News on Twitter
 
TOP STORY
LARGE Glycans on Dystroglycan Function as a Tunable Matrix Scaffold to Prevent Dystrophy
Researchers showed that coordinated upregulation of like-acetylglucosaminyltransferase (Large) and dystroglycan in differentiating mouse muscle facilitates rapid extension of LARGE-glycan repeat chains. Using synthesized LARGE-glycan repeats they showed a direct correlation between LARGE-glycan extension and its binding capacity for extracellular matrix ligands. [Nature] Abstract
NPCs from hPSCs in 6 Days: a monolayer culture method for neural induction of hPSCs
 
PUBLICATIONS (Ranked by impact factor of the journal)
Multifunctional Polymer Scaffolds with Adjustable Pore Size and Chemoattractant Gradients for Studying Cell Matrix Invasion
Scientists used Direct Laser Writing to fabricate 3D cell culture scaffolds with adjustable pore sizes (2-10 μm) on a microporous carrier membrane for applying diffusible chemical gradients. Mouse embryonic fibroblasts invade 10 μm pore scaffolds even in absence of chemoattractant, but invasion is significantly enhanced by knockout of lamin A/C, a known regulator of cell nucleus stiffness. [Biomaterials] Abstract

A Biomimetic Extracellular Matrix for Cartilage Tissue Engineering Centered on Photocurable Gelatin, Hyaluronic Acid and Chondroitin Sulfate
The authors encapsulated human chondrocytes in Gel-methacrylamide-based hydrogels, and showed that with the incorporation of small quantities of photocrosslinkable hyaluronic acid methacrylate, and to a lesser extent chondroitin sulfate methacrylate, chondrogenesis and mechanical properties can be enhanced. [Acta Biomater] Abstract

BMP-2 Induces Versican and Hyaluronan that Contribute to Post-EMT AV Cushion Cell Migration
Scientists explored the role of BMP-2 in the regulation of valvulogenic extracellular matrix components, versican and hyaluronan, and cell migration during post-EMT atrioventricular (AV) cushion distal outgrowth/expansion. [PLoS One] Full Article

Heparin-Dependent Regulation of Fibronectin Matrix Conformation
Using their dual antibody approach, researchers showed that heparin and mechanical strain co-regulate fibronectin (Fn) conformation in matrix fibrils, which is the first demonstration of heparin-dependent regulation of Fn in its physiologically-relevant fibrillar state. [Matrix Biol] Abstract

Preparation of Cardiac Extracellular Matrix Scaffolds by Decellularization of Human Myocardium
Myocardial extracellular matrix (ECM) from animals has been produced by whole-organ perfusion or immersion processes, but methods for preparation of human myocardial ECM for therapy and research have not been defined, yet. Investigators analyzed the impact of decellularization processes on human myocardial ECM, and tested its ability to serve as a scaffold for cell seeding. [J Biomed Mater Res A] Abstract

Nanoscale Architecture and Cellular Adhesion of Biomimetic Collagen Substrates
The authors demonstrated the production of synthetic human collagen using yeast strains that were engineered with human prolyl hydroxylase α and β genes integrated into the genome and a codon-optimized collagen gene carried on a plasmid. To understand the extent to which this synthetic collagen can mimic native human collagen, they examined the relationships between the structural topology and physical stability with the ability to support adhesion of HT-1080 cells. [J Biomater Appl] Abstract

Coating with Artificial Matrices from Collagen and Sulfated Hyaluronan Influences the Osseointegration of Dental Implants
Dental titanium implants were coated with an artificial extracellular matrix consisting of collagen type I and either one of two regioselectively low sulfated hyaluronan derivatives and compared to commercial pure titanium implants. [J Mater Sci Mater Med] Abstract

Use TeSR-E7 to generate iPS cells with high quality colony morphology for easy identification and rapid subcloning. Request your sample.
 
REVIEWS
Dynamic Cell-Cell and Cell-ECM Interactions in the Heart
Better understanding of cell-cell and cell-extracellular matrix (ECM) interactions and their biological consequences should provide novel therapeutic targets for the treatment of heart disease. In this review, the authors discuss the nature of these interactions and the importance of these interactions in maintaining normal heart function, as well as their role in the cardiac remodeling process. [J Mol Cell Cardiol] Abstract

Visit our reviews page to see a complete list of reviews in the extracellular matrix research field.
 
INDUSTRY NEWS
Baxter Launches HEMOPATCH, an Innovative Sealing Hemostat, in European Union
Baxter International Inc. announced the launch of HEMOPATCH Sealing Hemostat, a novel collagen-based hemostatic device, following CE mark approval in Europe. HEMOPATCH is a resorbable hemostatic device used for surgical procedures when control of bleeding by pressure, ligature or conventional procedures is either ineffective or impractical. [Baxter International Inc.] Press Release

SWOG Initiates Randomized Phase II Clinical Trial of Halozyme’s PEGPH20 in Combination with Modified FOLFIRINOX for Advanced Pancreatic Cancer
Halozyme Therapeutics, Inc. announced the initiation of a Phase Ib/II randomized clinical trial of Halozyme’s investigational drug PEGPH20 (PEGylated Recombinant Human Hyaluronidase) in combination with modified FOLFIRINOX chemotherapy (mFOLFIRINOX) compared to mFOLFIRINOX treatment alone in patients with metastatic pancreatic adenocarcinoma. [Halozyme Therapeutics, Inc.] Press Release

From our sponsor:
Pluripotent cell isolation for regenerative medicine. Request a free wallchart from Nature.
 
POLICY NEWS
National Institutes of Health (United States)

Food and Drug Administration (United States)

Center for Biologics Evaluation and Research (United States)

European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)
 
EVENTS
NEW Gordon Research Conferences: Proteoglycans – Diverse Regulators of Health and Disease
July 6-11, 2014
Anhover, United States

Visit our events page to see a complete list of events in the extracellular matrix community.
 
JOB OPPORTUNITIES
NEW PhD Position – Extracellular Matrix Research (Nencki Institute of Experimental Biology)

PhD Studentship – Molecular Force Sensors for Extracellular Matrix (Radboud University Nijmegen)

PhD Studentship – Collagen IV and Angiogenesis (University of East Anglia)

Assistant Professor – Department of Cell Biology and Anatomy (Rosalind Franklin University of Medicine and Science)

Postdoctoral Position – Tissue Engineering (Weizmann Institute of Science)

PhD Position – Molecular Cell Biology (Weizmann Institute of Science)

Research Technologist – Human Pluripotent Stem Cell Products (STEMCELL Technologies Inc.)

Research Associate/Scientist – Antibodies Group (STEMCELL Technologies Inc.)

Scientist – Particle Chemistry (STEMCELL Technologies Inc.)

Research Associate – Particle Chemistry (STEMCELL Technologies Inc.)


Recruit Top Talent: Reach more than 50,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
 

Have we missed an important article or publication in Extracellular Matrix News? Click here to submit!

Comments or Suggestions? Email [email protected] with your feedback.
Learn more about Extracellular Matrix News: Archives | Events | Contact Us